AGIOS PHARMACEUTICALS INC (AGIO) Stock Cash Flow
NASDAQ:AGIO - Nasdaq - US00847X1046 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 665.99M | 673.73M | -352.09M | -231.80M | 1.60B | |||
| Depreciation Amortization | 5.58M | 5.65M | 6.62M | 8.56M | 9.24M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | -27.29M | -19.77M | -19.06M | -16.43M | -36.82M | |||
| Taxes Paid | 43.86M | 43.15M | 1.57M | N/A | N/A | |||
| Other non cash items | -1.05B | -1.05B | 68.46M | -69.81M | -1.98B | |||
| OPERATING CASH FLOW | -401.46M | -389.84M | -296.06M | -309.48M | -407.32M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.31M | -1.69M | -999.00K | -4.88M | -5.74M | |||
| Other Investing Activity | 353.78M | 365.13M | 240.57M | 248.14M | 1.25B | |||
| INVESTING CASH FLOW | 351.47M | 363.44M | 239.57M | 243.26M | 1.25B | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 0.00 | -330.00K | -580.00K | |||
| Stock Issued/Repurchased | 10.20M | 14.44M | 5.43M | 2.68M | -765.19M | |||
| Other Financing Activity | N/A | N/A | N/A | 0.00 | 0.00 | |||
| FINANCING CASH FLOW | 10.20M | 14.44M | 5.43M | 2.35M | -765.77M | |||
| CHANGE IN CASH | -39.80M | -11.96M | -51.05M | -63.87M | 75.69M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -401.46M | -389.84M | -296.06M | -309.48M | -407.32M | |||
| Capital Expenditure | -2.31M | -1.69M | -999.00K | -4.88M | -5.74M | |||
| FREE CASH FLOW | -403.77M | -391.53M | -297.06M | -314.36M | -413.06M | |||
All data in USD